Overall rank by patents
#22,199
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
According to USPTO PatentsView, Aquisense ranks #22,199 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R22199 · US Corporation #22,199 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: APEX Material Technology Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Aquisense · this assignee
33 score
3D Lighting Innovati… · lowest
7 score
What this shows Aquisense's Innovation Score is 32.9/100 (top 57% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Aquisense Technologies, Llc is a focused PatentsView assignee: 6 CPC subclasses with 75% of grants classified under A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2019. By volume, Aquisense sits between APEX Material Technology Corp. and Arrowhead Medical Device Technologies, Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
APEX MATERIAL TECHNOLOGY CORP.
12 patents
APOGEE LIGHTING HOLDINGS, LLC
12 patents
APS JAPAN CO., LTD.
12 patents
AQ MEDIA, INC.
12 patents
ARAVEN, S.L.
12 patents
ARC HOLDINGS
12 patents
ARIES CLEAN TECHNOLOGIES LLC
12 patents
ARROWHEAD MEDICAL DEVICE TECHNOLOGIES, LLC
12 patents
AQUISENSE TECHNOLOGIES, LLC
12 patents
What this shows Aquisense holds 12 patents at rank #22,156, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,156 in granted patent volume.
Other assignees with the most granted patents in Aquisense's primary technology class.
Aquisense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 Top 57% higher than 43% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 25.0% |
| 2018 | 3 | 25.0% |
| 2019 | 1 | 8.3% |
| 2020 | 1 | 8.3% |
| 2021 | 2 | 16.7% |
| 2022 | 1 | 8.3% |
| 2023 | 1 | 8.3% |
Top 6 of 6 technology areas
Overall rank by patents
#22,199
of 50,000 tracked assignees
32.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.